ANJESO® is the first and only once daily IV analgesic. It is indicated in adults for the treatment of moderate to severe pain, alone or in combination with non-NSAID analgesics. Because of delayed onset of action, ANJESO alone is not recommended for use when rapid acting analgesia is required.
AJOVY is indicated for the preventive treatment of migraine in adults.
Click below to learn more.
IMPORTANT SAFETY INFORMATION
Contraindications:AJOVY is contraindicated in patients with serious hypersensitivity to fremanezumab-vfrm or to any of the excipients.
Click to see continued safety information and to download the full Prescribing Information.
The SPRINT® PNS System is a minimally-invasive treatment option that helps patients get back to life. The MicroLead™ is implanted and then removed after treatment of up to 60 days. Patients can easily adjust the level of stimulation during treatment to comfortably provide pain relief.